Resize Text Search
  • Call 888.905.6071
  • Request an appointment
  • MyChart current patient scheduling
General Inquiries

Knights Templar Eye Foundation Awards Grant to Summa’s Dr. Rachida Bouhenni

Date: 06.10.2014
Contact: Jim Gosky Phone: (234) 312-5052

AKRON, OH June 10, 2014 – The Knights Templar Eye Foundation recently presented a “Career-Starter Research Grant” of $60,000 to Summa Health System’s Rachida Bouhenni, Ph.D., to help advance her research into the causes of primary congenital glaucoma. Dr. Bouhenni is an Ophthalmology Research scientist at Summa.

Knights Templar Eye Foundation representative Larry Brown presented the award to Dr. Bouhenni on June 2 during Post-Graduate Day, an annual event showcasing resident research at Summa’s Akron City and St. Thomas hospitals.

A serious but rare disease, primary congenital glaucoma (PCG) affects about one in every 10,000 infants. It’s commonly diagnosed between the ages of three and six months, but can sometimes go undetected until as late as three years of age. If treated early, most children respond well with no future vision problems. The cause of the disease, which is brought on by increased pressure in the eye, is not clearly understood, but family history appears to play some part. The genetic causes of PCG partially overlap with adult-onset primary open-angle glaucoma, the most common form of glaucoma. Dr. Bouhenni’s research is focused on understanding the molecular mechanisms of the different types of glaucoma.

About the Knights Templar Eye Foundation
The Knights Templar Eye Foundation, Inc., based in Flower Mound, TX, supports research that can help launch the careers of clinical or basic researchers committed to the prevention and cure of potentially blinding diseases in infants and children. The Foundation supports clinical or basic research on conditions that can or may eventually be treated or prevented. Examples include amblyopia, congenital cataract, congenital glaucoma, retinopathy of prematurity, ocular malformations, congenital nystagmus, and other hereditary eye diseases such as retinal dystrophies or retinoblastoma.
About Summa Health System
Summa Health System is one of the largest integrated healthcare delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and the Summa Foundation, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa's clinical services are consistently recognized by the American Nurses Credentialing Center (Magnet® status), U.S. News and World Report, Thomson Reuters and The Leapfrog Group. Summa also is a founding partner of the Austen BioInnovation Institute in Akron. For more information, visit or find us on Facebook at and Twitter at